Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML):: A European leukemia net study.

被引：3

作者：

Cilloni, Daniela ^{[1
]}

Renneville, A. ^{[2
]}

Hermitte, F. ^{[3
]}

Hills, R. K. ^{[4
]}

Daly, S. ^{[5
]}

Jovanovic, J. ^{[6
]}

Gottardi, E. ^{[1
]}

Fava, M. ^{[1
]}

Schnittger, S. ^{[7
]}

Izzo, B. ^{[8
]}

Nomdedeu, J. ^{[9
]}

Van der Heijden, A. ^{[10
]}

Van der Velden, V. ^{[11
]}

Rohon, P. ^{[12
]}

Ommen, H. ^{[13
]}

Polak, J. ^{[14
]}

Jansen, J. ^{[10
]}

Preudhomme, C. ^{[2
]}

Saglio, G. ^{[1
]}

Grimwade, D. ^{[6
]}

机构：

[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy

[2] Hop Calmette, Dept Hematol, Lille, France

[3] Res & Dev, Ipsogen, Marseille, France

[4] Cardiff Univ, Dept Haematol, Cardiff, Wales

[5] Mission Res Inc, Dept Haematol, Manchester, Lancs, England

[6] Kings Coll London, Dept Genet, London WC2R 2LS, England

[7] MLL, Munich, Germany

[8] Univ Naples Federico 2, Dept Hematol, Naples, Italy

[9] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain

[10] UMCN St Radboud, Dept Hematol, Nijmegen, Netherlands

[11] Erasmus MC, Dept Immunol, Rotterdam, Netherlands

[12] Fac Hosp, Dept Hematol, Olomouc, Czech Republic

[13] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark

[14] Inst Hematol, DNA Diag, Prague, Czech Republic

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

10.1182/blood.V110.11.542.542

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

542

引用

页码：167A / 167A

页数：1

共 50 条

[1] EARLY ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) BY OPTIMIZED REAL-TIME QUANTITATIVE PCR (RQ-PCR) ASSAY FOR DETECTION OF WT1 TRANSCRIPTS PROVIDES AN INDEPENDENT PREDICTOR OF DISEASE RELAPSE IN ACUTE MYELOID LEUKEMIA: A EUROPEAN LEUKEMIANET (ELN) STUDY
Cilloni, D.
Renneville, A.
Hermitte, F.
Hills, R. K.
Daly, S.
Jovanovic, J.
Gottardi, E.
Fava, M.
Schnittger, S.
Weiss, T.
Izzo, B.
Nomdedeu, J.
van der Heijden, A.
van der Reijden, B.
van der Velden, V.
Rohon, P.
Ommen, H.
Polak, J.
Jansen, J.
Preudhomme, C.
Saglio, G.
Grimwade, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 169 - 169
[2] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
Cilloni, Daniela
Renneville, Aline
Hermitte, Fabienne
Hills, Robert K.
Daly, Sarah
Jovanovic, Jelena V.
Gottardi, Enrico
Fava, Milena
Schnittger, Susanne
Weiss, Tamara
Izzo, Barbara
Nomdedeu, Josep
van der Heijden, Adrian
van der Reijden, Bert A.
Jansen, Joop H.
van der Velden, Vincent H. J.
Ommen, Hans
Preudhomme, Claude
Saglio, Giuseppe
Grimwade, David
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5195 - 5201
[3] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
S Viehmann
A Teigler-Schlegel
J Bruch
C Langebrake
D Reinhardt
J Harbott
Leukemia, 2003, 17 : 1130 - 1136
[4] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
Viehmann, S
Teigler-Schlegel, A
Bruch, J
Langebrake, C
Reinhardt, D
Harbott, J
LEUKEMIA, 2003, 17 (06) : 1130 - 1136
[5] Quantitative analysis of WT1 gene for detection of minimal residual disease in acute leukemia by real-time RT-PCR
Ghaffari, S. H.
Hemmati, T.
Rostami, S.
Alimoghaddam, K.
Ghavamzadeh, A.
EJC SUPPLEMENTS, 2005, 3 (02): : 285 - 285
[6] A new method of Wilms' tumor gene WT1 quantitative assay (WT1 assay) based on real-time PCR for the detection of minimal residual disease (MRD) in patients with leukemia and myelodysplastic syndromes (MDS)
Tamaki, H
Ogawa, H
Oka, Y
Soma, T
Sugiyama, H
LEUKEMIA, 2001, 15 (12) : 2024 - 2024
[7] Real-time quantitative polymerase chain reaction (RQ-PCR) monitoring of minimal residual disease (MRD) in core binding factor acute myeloid leukaemia (CBF AML).
Lane, Steven W.
Saal, Russell
Mollee, Peter
Grigg, Andrew
Taylor, Kerry
Seymour, John Francis
Kennedy, Glen
Williams, Bronwyn
Jones, Mark
Grimmett, Karen
Griffiths, Vanessa
Gill, Devinder
Hourigan, Matthew
Marlton, Paula
BLOOD, 2006, 108 (11) : 651A - 651A
[8] Real-time PCR for quantitative detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL)
Pongers-Willemse, MJ
Verhagen, OJHM
Tibbe, GJM
Wijkhuijs, JM
De Haas, V
Van Wering, ER
Van der Schoot, CE
Van Dongen, JJM
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 292 - 292
[9] Quantitation of minimal residual disease (MRD) in TEL/AML1 positive patients during treatment by real-time quantitative RT-PCR (RQ-PCR)
Ballerini, P
Landman-Parker, J
Blaise, A
Laurendeau, I
Vidaud, M
Adam, M
Auvrignon, A
Leverger, G
Douay, L
Cayre, YE
Bièche, I
LEUKEMIA, 2001, 15 (12) : 2018 - 2018
[10] Assessment of minimal residual disease (MRD) by qualitative RT-PCR (Q-PCR) vs real-time quantitative RT-PCR (RQ-PCR) in a phase II study of acute promyelocytic leukemia (APL)
Gallagher, RE
Schachter-Tokarz, EL
Jones, DA
Estey, EH
BLOOD, 2005, 106 (11) : 912A - 912A

← 1 2 3 4 5 →